Multiple dosing of ephedra-free dietary supplements: hemodynamic, electrocardiographic, and bacterial contamination

L Foster1, M C Allan, A Khan

  • 1Department of Dietetics and Nutrition, College of Health Professions University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.

Insights

Ephedra-free dietary supplements can significantly increase heart rate and blood pressure, posing risks for individuals with cardiovascular conditions. Some supplements also contained harmful bacterial contamination.

Area of Science:

  • Cardiovascular Pharmacology
  • Dietary Supplement Analysis
  • Human Physiology

Background:

  • Ephedra alkaloids were removed from many dietary supplements due to safety concerns.
  • Ephedra-free alternatives are widely used for weight loss and athletic performance.
  • The cardiovascular safety of ephedra-free supplements requires thorough investigation.

Purpose of the Study:

  • To evaluate the cardiovascular effects of popular ephedra-free dietary supplements.
  • To assess the impact on heart rate (HR), blood pressure (BP), and electrocardiographic (ECG) parameters.
  • To determine caffeine content and identify potential contaminants in these supplements.

Main Methods:

  • A randomized, crossover study involving 12 healthy men.
  • Administration of four ephedra-free supplements with a 21-day washout period.
  • Continuous Holter monitoring for ECG and HR; automated BP measurements.
  • Analysis of caffeine content, microbial load, and serum caffeine levels.

Main Results:

  • Significant increases in systolic and diastolic blood pressure (SBP/DBP) were observed.
  • All supplements led to increased heart rate and decreased bradycardia runs.
  • Frequent abnormal atrial/ventricular events and sympathomimetic symptoms were reported.
  • Two supplements showed heavy contamination with Bacillus species.

Conclusions:

  • Ephedra-free dietary supplements can adversely affect cardiovascular parameters.
  • The use of these supplements is not recommended for individuals with pre-existing cardiovascular conditions.
  • Contamination with microbial species poses an additional health risk.

Related Concept Videos

Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Pharmacodynamic Responses: Different Types01:03

Pharmacodynamic Responses: Different Types

Pharmacodynamics is the scientific study of a drug's biochemical or physiological influence on the body. It categorizes responses into continuous, discrete (or categorical), and time-to-event outcomes. Continuous responses yield numerical values within a certain range, such as blood pressure readings and blood glucose levels, gauging the efficacy of antihypertensive and antidiabetic drugs. Discrete responses can be binary, indicating whether a drug has an effect or not, or ordinal, exemplifying...